NeuroPace Lands $49,126,004 New Round

  • Feed Type
  • Date
    8/31/2011
  • Company Name
    NeuroPace
  • Mailing Address
    1375 Shorebird Way Mountain View, CA 94043
  • Company Description
    NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders by responsive brain stimulation. The company’s initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.
  • Website
    http://www.neuropace.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $49,126,004
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy